Their study also showed that NETs have better tumor serodiagnostic capabilities than routine biomarkers, like carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) in GC. This evidence concerns the gene CEACAM5 and gastric cancer.